Vaccine Significantly Reduces the Severity of Covid 19 Infection: Evidence from a Community Based Study

Nitin Ashokbhai  Lodha; Bipin  Prajapati; Himanshu  Joshi; Mukesh  Dinkar

doi:10.55489/njcm.1332022399

Authors

Nitin Ashokbhai Lodha GMERS Medical College, Vadnagar
Bipin Prajapati GMERS Medical College, Himmatnagar
Himanshu Joshi GMERS Medical College, Vadnagar
Mukesh Dinkar GMERS Medical College, Vadnagar

DOI:

https://doi.org/10.55489/njcm.1332022399

Keywords:

Coronavirus disease, Covid-19, Vaccine, Hospitalization

Abstract

Background: Coronavirus disease is an infectious disease caused by newly discovered coronavirus (SARS-CoV-2), which spread rapidly throughout the world. Vaccines will provide a lasting solution by enhancing immunity and containing disease spread. This study was conducted to find out vaccination status among Covid-19 positive patients and correlate severity of infections with vaccination status.

Methodology: This cross sectional study was carried out among 1218 Covid-19 positive patients that were positive after the launch of Covid-19 vaccine, selected by purposive sampling method. Data was collected using pretested semi structured proforma.

Results: Covid-19 vaccination coverage was very low (10.03%) in Covid-19 positive patients, for single dose it was 8.38% and for two doses it was 1.65%. Asymptomatic and mild cases were more in vaccinated compared to unvaccinated, it was statistically significant. Though hospitalization in vaccinated was less it was not significant. There was no death among vaccinated cases.

Conclusion: Vaccination coverage were very low, this needs to improve. Vaccine was significantly reduces the severity of infection. It is recommended to vaccinate all eligible population as early as possible which will help in reducing severe and hospitalized cases and ultimately reducing the impact of Covid-19 pandemic..

References

Ministry of health and family walfare, Government of India. Covid-19 Vaccines, operational guidelines, updated as on 28 December 2020, p9. Available at: https://main.mohfw.gov.in/newshighlights-31.

Guidance note for COWIN 2.0. Available at: https://www.mohfw.gov.in/pdf/GuidancedocCOWIN2.pdf. Accessed August 16th 2021.

Revised Guidelines for implementation of National COVID Vaccination Program. Available at: https://www.mohfw.gov.in/pdf/RevisedVaccinationGuidelines.pdf. Accessed August 18th 2021.

COVID-19 Vaccine Breakthrough Case Investigation and Reporting. Available at: https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html. Accessed August 18th 2021.

The Possibility of COVID-19 after Vaccination: Breakthrough Infections. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/why-measure-effectiveness/breakthrough-cases.html. Accessed July 30th 2021

Clinical management protocol for Covid-19 (in adults), Government of India, Ministry of Health and Family welfare. Available at: https://www.mohfw.gov.in/pdf/UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.pdf. Accessed December 16th 2021.

Clinical guidance for management of adult Covid-19 patients, AIIMS/ICMR-COVID19 National task force/joint monitoring group (Dte. GHS), Ministry of Health and family welfare, Government of India. Available at: https://www.mohfw.gov.in/pdf/COVID19ClinicalManagementProtocolAlgorithmAdults19thMay2021.pdf. Accessed December 16th 2021.

Patel P, Chodvadiya K. A Study on Correlation of COVID-19 Vaccination and Hospitalization among Adults Aged 45 Years and Above: A Hospital Based Case Control Study. Natl J Community Med 2021;12(7):211-214.

Bhandari S, Bhargava A, Sharma S, et al. Clinical Profile of Covid-19 Infected Patients Admitted in a Tertiary Care Hospital in North India. J Assoc Physicians India. 2020;68(5):13-17.

Soni SL, Kajal K, Yaddanapudi LN, el al. Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India. Indian J Med Res. 2021;153(1): 115-125. https://doi.org/10.4103/ijmr.IJMR_2311_20

Mohan A, Tiwari P, Bhatnagar S, et al. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res. 2020;152(1): 61-69. https://doi.org/10.4103/ijmr.IJMR_1788_20

Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022; 22: 43-55. https://doi.org/10.1016/S1473-3099(21)00460-6

Clinical management of COVID-19: interim guidance. Geneva: World Health Organization; 2020 (https://www.who.int/ publications/i/item/clinical-management-of-covid-19, accessed 17th December 2021).

Government of India. COVID-19 Dashboard. Available at https://www.mygov.in/covid-19

Draft landscape and tracker of COVID-19 candidate vaccines. Geneva: World Health Organization; 2021 (https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines, accessed 19 April 2021).

Voysey M, Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021 Jan 9;397(10269):99-111.

Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®. Hyderabad: Bharat Biotech: 21 April 2021. https://www.bharatbiotech.com/images/ press/ covaxin-phase3-clinical-trials-interim-results.pdf.